Abstract
Deregulated signal transducer and activator of transcription 3 (STAT3) signaling has been well documented in certain cancers. Alterations in specific negative regulators, such as protein inhibitor of activated STAT3 (PIAS3), may contribute to cancer development. The expression of total PIAS3 was determined in 100 paired cancerous and non-cancerous breast tissues by immunoblotting and was statistically analyzed along with the clinicopathological characteristics and overall survival of the patients. XTT, immunoblotting, and chromatin immunoprecipitation (Chip) were used to examine the biological effect of PIAS3 in breast cancer cells. Hormone therapy failed to improve the overall survival in patients presenting with increased PIAS3 expression. Ectopic PIAS3 overexpression increased the proliferation and expression of cyclin D1 in estrogen receptor (ER)-positive MCF-7 and T47D cells, but decreased those in ER-negative MDA-MB-231 and SKBR3 cells. Furthermore, PIAS3 overexpression attenuated cytotoxicity of tamoxifen and increased proliferation and cyclin D1 expression in MCF-7 cells. PIAS3 also decreased the binding of itself on the cyclin D1 promoter and this decreased binding was not affected by tamoxifen. PIAS3 may serve as a bi...Continue Reading
References
Dec 31, 1997·Science·C D ChungK Shuai
May 5, 1998·Molecular and Cellular Biology·J F BrombergJ E Darnell
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·M SabbahG Redeuilh
Mar 16, 2001·Breast Cancer Research : BCR·J Bromberg
Jun 29, 2001·The Journal of Biological Chemistry·L H WangW L Farrar
Dec 26, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qian ZhangMariusz A Wasik
Mar 6, 2002·The Journal of Biological Chemistry·Barbara A WibleArthur M Brown
May 3, 2002·The Journal of Biological Chemistry·Meng-Min LiuPeter J Kushner
Jun 18, 2005·Molecular Endocrinology·Stephanie SentisLaura Corbo
Jun 2, 2006·The British Journal of Surgery·S-N WangK-T Lee
Aug 12, 2006·Journal of Clinical Pathology·Sheau-Fang YangKing-Teh Lee
Oct 13, 2006·Neoplasia : an International Journal for Oncology Research·Yoshitaka OgataIchiro Kawase
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·Amy KlugeAfshin Dowlati
Apr 8, 2010·Molecular Cancer Research : MCR·Corina BorghoutsBernd Groner
Feb 22, 2011·Clinics and Research in Hepatology and Gastroenterology·Liang-ming LiuJi-xiang Zhang
Apr 19, 2011·Molecular Oncology·Amy KlugeAfshin Dowlati
Dec 6, 2011·BMC Cancer·Wen-Yong WuXiang-Ling Meng
Dec 6, 2011·PloS One·Janeen AzareJacqueline Bromberg
Dec 17, 2011·EMBO Molecular Medicine·Yun-Yong ParkJu-Seog Lee
Jan 3, 2012·Molecular Diagnosis & Therapy·Richeng JiangKai Li
Mar 1, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Amir SonnenblickTamar Peretz
Aug 16, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Snehal DabirAfshin Dowlati
Citations
Oct 5, 2017·The Journal of Biological Chemistry·Anna M KnittleKlaus Elenius
Jan 13, 2018·Bioscience Reports·Shuntao WangLixiu Yu
Apr 21, 2017·Oncotarget·Amrita Singh ChandhokeShirin Bonni
Dec 6, 2017·International Journal of Oncology·Amir SonnenblickChristos Sotiriou
Aug 28, 2020·Frontiers in Oncology·Linn NilssonHelena Jernström
Aug 10, 2021·Journal of Clinical Laboratory Analysis·Yang XuYuhai Zhang